NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

391 hedge funds and large institutions have $9.56B invested in Neurocrine Biosciences in 2019 Q4 according to their latest regulatory filings, with 109 funds opening new positions, 137 increasing their positions, 103 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
391
Holders Change
+59
Holders Change %
+17.77%
% of All Funds
7.72%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.16%
New
109
Increased
137
Reduced
103
Closed
41
Calls
$93.9M
Puts
$56.8M
Net Calls
+$37.1M
Net Calls Change
+$33.9M

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$79.5M
2
BlackRock
2
BlackRock
New York
$709M
3
State Street
3
State Street
Massachusetts
$264M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$784M
5
Ameriprise
5
Ameriprise
Minnesota
$36.6M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$786M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$793M
3
HM
3
HealthCor Management
New York
$86.7M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$6.35M
5
O
5
OrbiMed
New York
$101M
Name Holding Trade Value Shares
Change 		Shares
Change %
MIM
426
Macroview Investment Management
Maryland
– -$3K -37 Closed
GWAG
427
Garrett Wealth Advisory Group
Texas
– -$1.26K -14 Closed
14 15 16 17
18